دورية أكاديمية
أعرض في EDS

A clinical study on global TCM therapy in treating senile advanced non-small cell lung cancer.

التفاصيل البيبلوغرافية
العنوان: A clinical study on global TCM therapy in treating senile advanced non-small cell lung cancer.
المؤلفون: Cheng JH; Guangdong Provincial Traditional Chinese Medicine Hospital, Guangzhou, 510120, China. cjh-china@tom.cn, Liu WS, Li ZM, Wang ZG
المصدر: Chinese journal of integrative medicine [Chin J Integr Med] 2007 Dec; Vol. 13 (4), pp. 269-74.
نوع المنشور: Comparative Study; Evaluation Study; Journal Article
اللغة: English
بيانات الدورية: Publisher: Chinese Journal of Integrated Traditional and Western Medicine Press Country of Publication: China NLM ID: 101181180 Publication Model: Print Cited Medium: Print ISSN: 1672-0415 (Print) Linking ISSN: 16720415 NLM ISO Abbreviation: Chin J Integr Med Subsets: MEDLINE
أسماء مطبوعة: Publication: 2007- : Berlin : Chinese Journal of Integrated Traditional and Western Medicine Press : Springer
Original Publication: Beijing, China : Watertown, MA : Chinese Association of the Integration of Traditional and Western Medicine : China Academy of Traditional Chinese Medicine ; Distributed by Relaxing Natural Health, [2003]-
مواضيع طبية MeSH: Aged*, Carcinoma, Non-Small-Cell Lung/*therapy , Lung Neoplasms/*therapy , Medicine, Chinese Traditional/*methods, Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/economics ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Disease Progression ; Female ; Humans ; Lung Neoplasms/economics ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Medicine, Chinese Traditional/economics ; Middle Aged ; Retrospective Studies ; Survival Analysis ; Time Factors ; Treatment Outcome
مستخلص: Objective: To assess the clinical efficacy of global traditional Chinese medicine (TCM) therapy in treating senile advanced non-small cell lung cancer (NSCLC), with the aim of seeking a standardized, rational and economical way to treat advanced NSCLC in old patients.
Methods: A retrospective analysis and comparison was carried out in 86 patients with senile advanced NSCLC, 44 treated by global TCM (TCM group) and 42 by chemotherapy (control group) through dynamical observation on related indexes including tumor size, quality of life and the survival time, as well as on the fee for medical service at various time points in the course of the treatment.
Results: The changes of tumor size, score of clinical main symptoms and behavior condition (by ZPS scoring), as well as survival rates in the two groups at corresponding time points, were not different significantly (P>0.05). The mean survival time in the TCM group was 13.20+/-1.52 months and that in the chemotherapy group was 13.45+/-1.94 months, showing insignificant difference between them. However, the median survival time in the TCM group (12 months) was actually longer than that in the chemotherapy group (9 months, P<0.05). The mean daily expense and the mean expense (RMB yuan) for each patient in the TCM group were significantly lower than that in the control group, which was 180.73+/-93.21 vs 825.84+/-329.63 for the mean daily expense and 34077.21+/-14638.04 vs 58516.59+/-45429.76 for the mean expense for each patient (both P<0.01).
Conclusion: Treatment of senile advanced NSCLC with TCM alone has its apparent superiority in stabilizing tumor focus, improving clinical symptoms, elevating quality of life and prolonging the survival time. TCM is also less expensive, making it a good alternative therapeutic approach for this specific group of people.
References: Lung Cancer. 2000 Feb;27(2):75-80. (PMID: 10688490)
Cancer. 2000 Jul 15;89(2):328-33. (PMID: 10918162)
J Natl Cancer Inst. 1999 Jan 6;91(1):66-72. (PMID: 9890172)
Eur J Cancer. 1998 Oct;34(11):1710-4. (PMID: 9893657)
تواريخ الأحداث: Date Created: 20080109 Date Completed: 20080225 Latest Revision: 20191210
رمز التحديث: 20221213
DOI: 10.1007/s11655-007-0269-4
PMID: 18180891
قاعدة البيانات: MEDLINE
الوصف
تدمد:1672-0415
DOI:10.1007/s11655-007-0269-4